Literature DB >> 10348017

Buccal midazolam and rectal diazepam for epilepsy.

A Chattopadhyay, B Morris, L Blackburn, E Wassmer, W Whitehouse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10348017     DOI： 10.1016/S0140-6736(05)75898-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Intranasal midazolam for treating febrile seizures in children. Caution is advised in interpreting trial conclusions.

Authors:  T Johnson
Journal:  BMJ       Date:  2001-01-13

Review 2.  The treatment of convulsive status epilepticus in children. The Status Epilepticus Working Party, Members of the Status Epilepticus Working Party.

Authors:  R Appleton; I Choonara; T Martland; B Phillips; R Scott; W Whitehouse
Journal:  Arch Dis Child       Date:  2000-11       Impact factor: 3.791

3.  The cost effectiveness of licensed oromucosal midazolam (Buccolam(®)) for the treatment of children experiencing acute epileptic seizures: an approach when trial evidence is limited.

Authors:  Dawn Lee; Daniel Gladwell; Anthony J Batty; Nic Brereton; Elaine Tate
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.